BNTX

#4574
BioNTech SE American Depositary Share
110.23
+2.01%
Secteur:
Base:
Devise de Profit:
Range quotidien
110.23
110.48
Range Annuel
81.20
123.98
Changement quotidien
+2.01%
Changement Mensuel
-6.13%
Evolution sur 6 mois
+7.02%
Changement Annuel
+2.54%
Clôture Précédente
108.06
Open
110.48
Bid
Ask
Low
110.23
High
110.48
Volume
78
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 6 772
  • Founded 2008
  • CEO Uğur Şahin
  • Website www.biontech.de
  • Headquarter Germany
  • FIGI BBG00Q70B3V1
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

BioNTech SE - American Depositary Shares

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

Nouvelles